# Anti-inflammatory effect of a pimarane diterpenoid isolated from Nepeta adenophyta Hedge based on a network analysis approach and experimental assessment

**Authors:** Wei Zhao, Meng Li, Chuanqing Jia, Iftikhar Ali, Long Chen

PMC · DOI: 10.3389/fphar.2025.1652902 · Frontiers in Pharmacology · 2025-12-18

## TL;DR

A compound from Nepeta adenophyta shows anti-inflammatory effects by targeting key pathways like NF-κB and PPARγ.

## Contribution

The study identifies a pimarane diterpenoid from N. adenophyta and demonstrates its anti-inflammatory mechanism through experimental and network analysis.

## Key findings

- Compound 1 reduces pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6.
- It inhibits NF-κB p65 translocation and the expression of iNOS and COX-2.
- Compound 1 modulates the NF-κB and PPARγ pathways to exert anti-inflammatory effects.

## Abstract

As an important folk medicine in Pakistan, Nepeta adenophyta Hedge has been widely used to treat abdominal pain, kidney pain, headaches, and for the alleviation of dysmenorrhea. The pimarane-type diterpenoids are known for their anti-inflammatory activity, but their mechanistic pathways remain understudied. 2,4b,8,8-Tetramethyl-2-vinyl-1,2,3,4,4a,4b,5,6,7,8,8a,9-dodecahydro-phenanthrene-3,5-diol (1), a pimarane diterpenoid, was detected primarily from N. adenophyta Hedge through its gas chromatography-mass spectrometry (GC-MS) fragmentation pathways. The GC-MS-guided isolation yielded compound 1 (NAC, N. adenophyta compound) in pure form.

The GC-MS guided isolation of compound 1 was performed by column chromatography on normal silica gel. The structure was characterized by spectroscopic techniques. Then, the potential targets, pathways, and hub genes for treating inflammatory diseases were screened out through network analysis, and core targets were docked with 1 via docking software. Based on the results of network analysis, an MTT assay was performed to determine cell proliferation in the RAW264.7 cell line. Inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2), were tested by enzyme-linked immunosorbent assay (ELISA). Immunofluorescence and Western blot assays were used to verify the function of 1 in the treatment of inflammation.

Compound 1 was isolated from N. adenophyta Hedge in its pure form. The pharmaceutical network results showed that it has a potential anti-inflammatory effect through the PPAR and NF-κB signaling pathways. The ELISA results showed that 1 could attenuate the content of pro-inflammatory cytokines. Additionally, the translocation of NF-κB p65 into the nucleus was significantly decreased in the immunofluorescence method. The Western blot analysis results showed that 1 significantly inhibited the protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Furthermore, it decreased the phosphorylation of nuclear factor kappa B inhibitor α (IκBα) and toll-like receptor 4 (TLR4) by the NF-κB signaling pathway. Compound 1 also reduced reactive oxygen species (ROS) levels and restored overexpressed heme oxygenase-1 (HO-1) and serine/threonine kinase (AKT) to the basal level.

The present study indicates that compound 1 shows a significant anti-inflammatory effect, potentially through intervention in the NF-κB and PPARγ signaling pathways.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569], ptges2.L (prostaglandin E synthase 2 L homeolog) [NCBI Gene 100037123], NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792], TLR4 (toll like receptor 4) [NCBI Gene 7099], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513], HMOX1 (heme oxygenase 1) [NCBI Gene 3162], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** TED4 (Plant heme oxygenase (decyclizing) family protein), WAK1 (cell wall-associated kinase)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Map3k10 (mitogen-activated protein kinase kinase kinase 10) [NCBI Gene 269881] {aka MST, Mlk2}
- **Diseases:** headaches (MESH:D006261), inflammation (MESH:D007249), kidney pain (MESH:D007680), dysmenorrhea (MESH:D004412), Inflammatory cytokines (MESH:D000080424), abdominal pain (MESH:D015746)
- **Chemicals:** ROS (MESH:D017382), pimarane (MESH:C433018), MTT (MESH:C070243), 2,4b,8,8-Tetramethyl-2-vinyl-1,2,3,4,4a,4b,5,6,7,8,8a,9-dodecahydro-phenanthrene-3,5-diol (-), PGE2 (MESH:D015232), silica gel (MESH:D058428), diterpenoids (MESH:D004224)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12756164/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12756164/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12756164/full.md

---
Source: https://tomesphere.com/paper/PMC12756164